Clinical trial registry record

Effects of Monarda Didyma Extract Supplementation on Biological Ageing

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated June 6, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05399966
Last registry update
June 6, 2024
Status
Completed
Phase
Phase not reported
Sponsor
Sofia Pavanello
Enrollment
81
Countries
Italy
Match confidence
80%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · OTHER · QUADRUPLE
Evidence population
Human clinical study registration
Participants
81
Population
ALL · 45 Years to 65 Years
Duration
2023-02-28 to 2024-01-30
Intervention
Monarda Didyma extract; Placebo
Comparator
Placebo
Outcomes measured
DNA methylation age (DNAmAge) — 12 weeks; Age acceleration (AgeAcc) — 12 weeks; Leukocyte telomere length (LTL) — 12 weeks; Mitochondrial DNA copy number (mtDNAcn) — 12 weeks; Telomerase expression (∆∆Ct) — 12 weeks; Blood pressure — 12 weeks; Salivary cortisol — 12 weeks; Leukocytes — 12 weeks; erythrocytes — 12 weeks; hemoglobin — 12 weeks; hematocrit — 12 weeks; MCV mean corpuscular volume — 12 weeks; MCH mean corpuscular hemoglobin — 12 weeks; MCHC mean corpuscular hemoglobin concentration — 12 weeks; platelets — 12 weeks; C reactive protein — 12 weeks; interleukin 6 — 12 weeks; Questionnaire about Quality of Life: World Health Organization's Quality of Life Assessment BREF version (WHOQOL-BREF)…; Questionnaire about sleeping patterns: Pittsburgh Sleep Quality Index (PSQI) — 12 weeks; Tracking of Hearth Rate using Miband 6 watch — 12 weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 80% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Biological age biomarkers · 80%Title contains controlled topic terminology. Title supplies ageing or longevity context.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

biological age biomarkers
Read the original source →Export JSON